Baricitinib Scores High in Phase III (CME/CE)

(MedPage Today) -- Superior to adalimumab for clinical and functional outcomes
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics | Humira